OrganiGram Holdings Inc (OGI)
1.925
-0.02
(-1.28%)
USD |
NASDAQ |
Apr 24, 16:00
1.92
0.00 (0.00%)
After-Hours: 18:47
OrganiGram Holdings Cash from Financing (TTM): -0.5334M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.5334M |
May 31, 2023 | -0.5484M |
February 28, 2023 | -0.6396M |
November 30, 2022 | 4.254M |
August 31, 2022 | 4.187M |
May 31, 2022 | 1.183M |
February 28, 2022 | 132.27M |
November 30, 2021 | 89.34M |
August 31, 2021 | 137.53M |
May 31, 2021 | 178.26M |
February 28, 2021 | 63.32M |
November 30, 2020 | 141.51M |
August 31, 2020 | 119.27M |
May 31, 2020 | 88.68M |
February 29, 2020 | 109.11M |
November 30, 2019 | 71.16M |
August 31, 2019 | 56.07M |
May 31, 2019 | 48.46M |
February 28, 2019 | 8.151M |
November 30, 2018 | 136.14M |
August 31, 2018 | 128.25M |
May 31, 2018 | 129.19M |
February 28, 2018 | 133.67M |
Date | Value |
---|---|
November 30, 2017 | 32.22M |
August 31, 2017 | 30.89M |
May 31, 2017 | 54.29M |
February 28, 2017 | 53.90M |
November 30, 2016 | 25.42M |
August 31, 2016 | 28.13M |
May 31, 2016 | 6.457M |
February 29, 2016 | 6.150M |
November 30, 2015 | 6.935M |
August 31, 2015 | 5.011M |
May 31, 2015 | |
February 28, 2015 | |
November 30, 2014 | |
July 31, 2014 | |
April 30, 2014 | |
January 31, 2014 | |
October 31, 2013 | |
July 31, 2013 | |
April 30, 2013 | |
January 31, 2013 | |
October 31, 2012 | |
July 31, 2012 | |
April 30, 2012 | 0.3164M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.6396M
Minimum
Feb 2023
178.26M
Maximum
May 2021
69.05M
Average
67.24M
Median
Cash from Financing (TTM) Benchmarks
Tilray Brands Inc | -76.02M |
Clever Leaves Holdings Inc | 0.656M |
Flora Growth Corp | 3.15M |
Acasti Pharma Inc | 7.359M |
Aurinia Pharmaceuticals Inc | -5.13M |